Ezetimibe
Links shared publicly online about this topic
Generic ezetimibe
theheart.org — “Glenmark Pharmaceuticals filed an abbreviated new drug application with the FDA in October 2006, and product launch of generic ezetimibe will depend on its final approval by the agency.” View full resource at theheart.org
Most Recently Shared on April 28, 2009 at 7:48 pm By:
heartwire: Mumbai-based company gets tentative approval for generic ezetimibe http://bit.ly/15K34l
Ezetimibe and cancer
theheart.org — “Over a four-year period, the rates of cancer-associated adverse events and the proportion of all reported adverse events related to cancer were less than event rates observed with other potent cholesterol-lowering medications.” View full resource at theheart.org
Most Recently Shared on March 25, 2009 at 10:01 pm By:
FDA postmarketing surveillance data show no cancer risk with ezetimibe http://tinyurl.com/cazb7s
Ezetimibe and cancer risk
theheart.org — “Based on current information, the agency said an association between ezetimibe and cancer risk or cancer-related mortality is not likely, although this association can't be definitively ruled out yet.” View full resource at theheart.org
Most Recently Shared on December 22, 2009 at 9:39 pm By:
FDA says cancer risk with ezetimibe is unlikely http://bit.ly/7KabXf #heartwire
Pulse - Ezetimibe reduces vascular events
pulsetoday.co.uk — “Pulse - Ezetimibe reduces vascular events” View full resource at pulsetoday.co.uk
Most Recently Shared on November 29, 2010 at 10:17 am By:
PulseToday Health News and Medical Publisher
Ezetimibe reduces vascular events: A new investigational study appears to have shown for the first time that pre... http://bit.ly/eC68dI
The Benefit Of Ezetimibe Not Proven For Treatment Of Elevated Cholesterol Levels
medicalnewstoday.com — “Elevated blood cholesterol levels are regarded as a risk factor for heart attacks and other cardiovascular diseases. However, this does not necessarily mean that every cholesterol-lowering drug ca” View full resource at medicalnewstoday.com
Most Recently Shared on September 16, 2011 at 7:05 am By:
MNT Cholesterol News Health News
The Benefit Of Ezetimibe Not Proven For Treatment Of Elevated Cholesterol Levels http://mnt.to/3ZFt #cholesterol
Pulse - Concern over growing use of ezetimibe by GPs
pulsetoday.co.uk — “Pulse - Concern over growing use of ezetimibe by GPs” View full resource at pulsetoday.co.uk
Most Recently Shared on July 15, 2010 at 8:16 am By:
PulseToday Health News and Medical Publisher
Concern over growing use of ezetimibe by GPs: There is ‘no sound basis’ for the growing use of lipid-lowering drug... http://bit.ly/905QUm
Combined Effects of Ezetimibe and Phytosterols on Cholesterol Metabolism
circ.ahajournals.org — “Combined Effects of Ezetimibe and Phytosterols on Cholesterol Metabolism” View full resource at circ.ahajournals.org
Most Recently Shared on July 24, 2011 at 10:49 am By:
James Underberg Doctor, Internist, and Physician
Combined Effects of #Ezetimibe & #Phytosterols on #Cholesterol Metabolism in Humans cholesterol benefits but CV ? http://bit.ly/o4yDui #fb
Pulse - Concern over growing use of ezetimibe by GPs
pulsetoday.co.uk — “Pulse - Concern over growing use of ezetimibe by GPs” View full resource at pulsetoday.co.uk
Most Recently Shared on July 15, 2010 at 9:48 am By:
PulseToday Health News and Medical Publisher
Concern over growing use of ezetimibe by GPs: There is ‘no sound basis’ for the growing use of lipid-lowering drug... http://bit.ly/aBfd2N
ARBITER 6-HALTS: Niacin superior to ezetimibe
endocrinetoday.com — “American Heart Association Scientific Sessions 2009 Extended-release niacin was superior to ezetimibe when combined with statins for the red” View full resource at endocrinetoday.com
Most Recently Shared on November 16, 2009 at 3:22 pm By:
ARBITER 6-HALTS: Niacin superior to ezetimibe http://ow.ly/CKTK #AHA09
Cardiovascular Outcomes With Ezetimibe/Simvastatin Combination | Cardiology
medicexchange.com — “Cardiovascular Outcomes for Patients Treated With Ezetimibe/Simvastatin Combination Compared With Simvastatin or Atorvastatin Alone, a study presented at AHA.” View full resource at medicexchange.com
Most Recently Shared on November 23, 2009 at 1:52 pm By:
Alex van Klaveren Health Social Media
Latest News Cardiovascular Outcomes With Ezetimibe/Simvastatin Combination: Cardio.. http://bit.ly/08yViQp MedicExchange.com
Ezetimibe/Simvastatin Is More Effective Than Atorvastatin In Metabolic Syndrome
medicalnewstoday.com — “New data indicate that patients with metabolic syndrome have a greater likelihood of reaching specified lipid and high-sensitivity C-reactive protein (hs-CRP) levels if they are treated with ezet” View full resource at medicalnewstoday.com
Most Recently Shared on September 29, 2010 at 6:05 pm By:
Ezetimibe/Simvastatin Is More Effective Than Atorvastatin In Metabolic Syndrome http://mnt.to/3Kxr #healthnews
Merck Settles Patent Infringement Case For Zetia(R) (ezetimibe)
medicalnewstoday.com — “Merck & Co., Inc. and Glenmark Pharmaceuticals Inc., USA and Glenmark Pharmaceuticals, Ltd. have reached an agreement to settle their patent litigation involving Glenmark's challenge to Merck's pa” View full resource at medicalnewstoday.com
Most Recently Shared on May 11, 2010 at 11:11 pm By:
MNT Pharma News Pharma and Health News
Merck Settles Patent Infringement Case For Zetia(R) (ezetimibe) http://mnt.to/3CsX #pharma #pharmaceutical
Full ARBITER 6-HALTS results for niacin/ezetimibe study
theheart.org — “The final results of ARBITER 6-HALTS, which include an additional 107 patients who completed the closeout assessment after a mean of seven months of treatment, are line with the preliminary results showing that niacin added to statin therapy resulted in a significant regression of carotid IMT, whereas treatment with ezetimibe did not.” View full resource at theheart.org
Most Recently Shared on April 15, 2010 at 7:46 am By:
James Rudd Doctor, Internist, Cardiologist, and Physician
ARBITER 6-HALTS: Final results from complete study population published http://j.mp/9vV9CR
Full ARBITER 6-HALTS results for niacin/ezetimibe study
theheart.org — “The final results of ARBITER 6-HALTS, which include an additional 107 patients who completed the closeout assessment after a mean of seven months of treatment, are line with the preliminary results showing that niacin added to statin therapy resulted in a significant regression of carotid IMT, whereas treatment with ezetimibe did not.” View full resource at theheart.org
Most Recently Shared on April 14, 2010 at 9:25 pm By:
ARBITER 6-HALTS: Final results from complete study population published: The final results of ARBITER 6-HALT... http://bit.ly/9R2x2l #ACC10
Is prescribing of ezetimibe a rational use of NHS resources? NPCi blog - Jack's posterous
pharmagossip.posterous.com — “Is prescribing of ezetimibe a rational use of NHS resources? NPCi blog - Jack's posterous” View full resource at pharmagossip.posterous.com
Most Recently Shared on August 17, 2010 at 3:46 pm By:
Jack Friday - PharmaGossip Health Blog
Is prescribing of ezetimibe a rational use of NHS resources? « NPCi blog http://post.ly/sILH
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
Advertisement
